ChemicalBook >> CAS DataBase List >>Burosumab

Burosumab

CAS No.
1610833-03-8
Chemical Name:
Burosumab
Synonyms
KRN23;Burosumab;Burosumab (Anti-FGF23);Research Grade Burosumab;Research Grade Burosumab(DHJ53401)
CBNumber:
CB94919949
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:58:25

Burosumab Properties

form Liquid
color Colorless to light yellow
FDA UNII G9WJT6RD29
NCI Drug Dictionary burosumab
ATC code M05BX05

Burosumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0069788 Burosumab 99.20% 1610833-03-8 1mg $282 2026-06-04 Buy
ChemScene CS-0069788 Burosumab 99.20% 1610833-03-8 5mg $650 2026-06-04 Buy
ChemScene CS-0069788 Burosumab 99.20% 1610833-03-8 10mg $1040 2026-06-04 Buy
aablocks AA024W2B Burosumab ≥95%(SDS-PAGE&SEC-HPLC) 1610833-03-8 1mg $438 2026-06-01 Buy
aablocks AA024W2B Burosumab ≥95%(SDS-PAGE&SEC-HPLC) 1610833-03-8 5mg $1026 2026-06-01 Buy
Product number Packaging Price Buy
CS-0069788 1mg $282 Buy
CS-0069788 5mg $650 Buy
CS-0069788 10mg $1040 Buy
AA024W2B 1mg $438 Buy
AA024W2B 5mg $1026 Buy

Burosumab Chemical Properties, Uses, Production

Uses

Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].

References

[1] Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children. Front Endocrinol (Lausanne). 2020 May 28;11:338. DOI:10.3389/fendo.2020.00338
[2] Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1. DOI:10.1007/s00198-022-06617-2

Burosumab Preparation Products And Raw materials

Raw materials

Preparation Products

Burosumab Suppliers

Global Suppliers ( 23)
Supplier Tel Email Country ProdList Advantage
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
BOC Sciences 16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1577 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Wuhan Acumen Bio-Technology Co.,ltd 027-027-16602739303 16602739303 673003916@qq.com China 4593 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. 6206333 13167063860 anhua.mao@aladdin-e.com China 43553 58
Burosumab Research Grade Burosumab(DHJ53401) KRN23 Research Grade Burosumab Burosumab (Anti-FGF23) 1610833-03-8